ArticleJournal of nanobiotechnology2025

Targeting GDF15 to enhance immunotherapy efficacy in glioblastoma through tumor microenvironment-responsive CRISPR-Cas9 nanoparticles.

Cheng Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.